130
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Derivation and Validation of a Predictive Scoring Model of Infections Due to Acinetobacter baumannii in Patients with Hospital Acquired Pneumonia by Gram-Negative Bacilli

, , , , &
Pages 1055-1066 | Published online: 15 Mar 2022

References

  • Shi Y, Huang Y, Zhang TT, et al. Chinese guidelines for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults (2018 Edition). J Thorac Dis. 2019;11(6):2581–2616. doi:10.21037/jtd.2019.06.09
  • Chapartegui-González I, Lázaro-Díez M, Bravo Z, Navas J, Icardo JM, Ramos-Vivas J. Acinetobacter baumannii maintains its virulence after long-time starvation. PLoS One. 2018;13(8):e0201961. doi:10.1371/journal.pone.0201961
  • Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5(12):939–951. doi:10.1038/nrmicro1789
  • Zilberberg MD, Nathanson BH, Sulham K, Fan W, Shorr AF. Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis. Crit Care. 2016;20(1):221. doi:10.1186/s13054-016-1392-4
  • Yin Y, Zhao C, Li H, et al. Clinical and microbiological characteristics of adults with hospital-acquired pneumonia: a 10-year prospective observational study in China. Eur J Clin Microbiol Infect Dis. 2021;40(4):683–690. doi:10.1007/s10096-020-04046-9
  • Chung DR, Song JH, Kim SH, et al. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia. Am J Respir Crit Care Med. 2011;184(12):1409–1417. doi:10.1164/rccm.201102-0349OC
  • Wang Q, Wang Z, Zhang F, et al. Long-term continuous antimicrobial resistance surveillance among nosocomial Gram-negative Bacilli in China from 2010 to 2018 (CMSS). Infect Drug Resist. 2020;13:2617–2629. doi:10.2147/IDR.S253104
  • Garnacho-Montero J, Dimopoulos G, Poulakou G, et al. Task Force on management and prevention of Acinetobacter baumannii infections in the ICU. Intensive Care Med. 2015;41(12):2057–2075. doi:10.1007/s00134-015-4079-4
  • Vazquez Guillamet C, Kollef MH. Acinetobacter pneumonia: improving outcomes with early identification and appropriate therapy. Clin Infect Dis. 2018;67(9):1455–1462. doi:10.1093/cid/ciy375
  • Sullivan LM, Massaro JM, D’Agostino RB Sr. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med. 2004;23(10):1631–1660. doi:10.1002/sim.1742
  • Labarère J, Renaud B, Fine MJ. How to derive and validate clinical prediction models for use in intensive care medicine. Intensive Care Med. 2014;40(4):513–527. doi:10.1007/s00134-014-3227-6
  • Lasko TA, Bhagwat JG, Zou KH, Ohno-Machado L. The use of receiver operating characteristic curves in biomedical informatics. J Biomed Inform. 2005;38(5):404–415. doi:10.1016/j.jbi.2005.02.008
  • Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32–35. doi:10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
  • Kalil AC, Metersky ML, Klompas M, et al. Executive summary: management of adults with hospital-acquired and ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):575–582. doi:10.1093/cid/ciw504
  • Torres A, Niederman MS, Chastre J, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT). Eur Respir J. 2017;50(3):1700582.
  • Miller JM, Binnicker MJ, Campbell S, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018;67(6):e1–e94. doi:10.1093/cid/ciy381
  • Wu F, Hu R. Risk factors for pneumonia caused by antimicrobial drug-resistant or drug-sensitive Acinetobacter baumannii infections: a retrospective study. Medicine (Baltimore). 2020;99(28):e21051. doi:10.1097/MD.0000000000021051
  • Liu Q, Li W, Du X, et al. Risk and prognostic factors for multidrug-resistant Acinetobacter baumannii complex bacteremia: a retrospective study in a tertiary hospital of West China. PLoS One. 2015;10(6):e0130701. doi:10.1371/journal.pone.0130701
  • Torres A, Lee N, Cilloniz C, Vila J, Van der Eerden M. Laboratory diagnosis of pneumonia in the molecular age. Eur Respir J. 2016;48(6):1764–1778. doi:10.1183/13993003.01144-2016
  • Mendelson M, Matsoso MP. The World Health Organization global action plan for antimicrobial resistance. S Afr Med J. 2015;105(5):325. doi:10.7196/SAMJ.9644
  • Teysseyre L, Ferdynus C, Miltgen G, et al. Derivation and validation of a simple score to predict the presence of bacteria requiring carbapenem treatment in ICU-acquired bloodstream infection and pneumonia: carbaSCORE. Antimicrob Resist Infect Control. 2019;8:78. doi:10.1186/s13756-019-0529-z
  • Chen IL, Lee CH, Ting SW, Wang LY. Prediction of imipenem-resistant microorganisms among the nosocomial critically ill patients with Gram-negative bacilli septicemia: a simple risk score. Infect Drug Resist. 2018;11:283–293. doi:10.2147/IDR.S157200
  • Vasudevan A, Mukhopadhyay A, Li J, Yuen EG, Tambyah PA. A prediction tool for nosocomial multi-drug resistant Gram-negative Bacilli infections in critically ill patients - prospective observational study. BMC Infect Dis. 2014;14:615. doi:10.1186/s12879-014-0615-z
  • Tseng WP, Chen YC, Yang BJ, et al. Predicting multidrug-resistant Gram-negative bacterial colonization and associated infection on hospital admission. Infect Control Hosp Epidemiol. 2017;38(10):1216–1225. doi:10.1017/ice.2017.178
  • Madrid-Morales J, Sharma A, Reveles K, et al. Validation of available extended-spectrum-beta-lactamase clinical scoring models in predicting drug resistance in patients with enteric Gram-negative bacteremia treated at South Texas Veterans Health Care System. Antimicrob Agents Chemother. 2021;65(6). doi:10.1128/AAC.02562-20
  • Johnson SW, Anderson DJ, May DB, Drew RH. Utility of a clinical risk factor scoring model in predicting infection with extended-spectrum β-lactamase-producing Enterobacteriaceae on hospital admission. Infect Control Hosp Epidemiol. 2013;34(4):385–392. doi:10.1086/669858
  • Shu H, Li L, Wang Y, et al. Prediction of the risk of hospital deaths in patients with hospital-acquired pneumonia caused by multidrug-resistant Acinetobacter baumannii infection: a multi-center study. Infect Drug Resist. 2020;13:4147–4154. doi:10.2147/IDR.S265195